• 1. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 2. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 3. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 4. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
• 5. Excited state dynamics of symmetric and asymmetric Cr3(dpa)4Cl2 measured using femtosecond transient absorption spectroscopy?
  Chao-Han Cheng,Wen-Zhen Wang,Shie-Ming Peng,I-Chia Chen Phys. Chem. Chem. Phys., 2017,19, 25471-25477

Carbamic acid, bis(3-hydroxypropyl)-, 1,1-dimethylethyl ester (CAS No. 125763-80-6): A Comprehensive Overview

Carbamic acid, bis(3-hydroxypropyl)-, 1,1-dimethylethyl ester, identified by its CAS number 125763-80-6, is a compound of significant interest in the field of pharmaceutical chemistry and biochemistry. This compound, characterized by its unique structural features, has garnered attention due to its potential applications in drug development and molecular research. The presence of bis(3-hydroxypropyl) groups and the 1,1-dimethylethyl ester moiety imparts distinct chemical properties that make it a valuable candidate for various biochemical interactions.

The molecular structure of Carbamic acid, bis(3-hydroxypropyl)-, 1,1-dimethylethyl ester consists of a central carbamic acid core functional group, which is esterified at both carbonyl positions with 3-hydroxypropyl chains. The tert-butyl ester groups provide stability and influence the compound's solubility and reactivity. This structural configuration makes it an intriguing molecule for studying enzyme inhibition and substrate-enzyme interactions in biochemical pathways.

In recent years, the compound has been explored in the context of its role as a precursor in the synthesis of more complex pharmaceutical intermediates. Its bifunctional nature allows for selective modifications at both hydroxyl and carbonyl positions, making it a versatile building block in organic synthesis. Researchers have leveraged these properties to develop novel therapeutic agents targeting various diseases.

One of the most compelling aspects of Carbamic acid, bis(3-hydroxypropyl)-, 1,1-dimethylethyl ester is its potential application in the development of enzyme inhibitors. The hydrophilic nature of the 3-hydroxypropyl groups enhances its interaction with polar residues in enzymes, while the tert-butyl ester groups provide steric hindrance that can be tailored to fit specific active sites. This balance has led to promising results in the inhibition of key enzymes involved in metabolic pathways relevant to cancer and inflammation.

Recent studies have highlighted the compound's efficacy in modulating inflammatory responses. By inhibiting specific enzymes such as COX-2 and LOX-5, Carbamic acid, bis(3-hydroxypropyl)-, 1,1-dimethylethyl ester has shown potential in reducing pro-inflammatory cytokine production. This makes it a candidate for developing anti-inflammatory drugs with fewer side effects compared to traditional nonsteroidal anti-inflammatory drugs (NSAIDs).

The compound's stability under various conditions also makes it suitable for industrial applications in pharmaceutical manufacturing. Its resistance to hydrolysis and oxidation ensures that it can be stored and handled efficiently without significant degradation. This stability is crucial for maintaining the integrity of pharmaceutical intermediates during large-scale production processes.

In addition to its inhibitory properties, Carbamic acid, bis(3-hydroxypropyl)-, 1,1-dimethylethyl ester has been investigated for its role in drug delivery systems. The hydrophilic nature of the 3-hydroxypropyl groups facilitates water solubility, making it an ideal candidate for formulations that require controlled release profiles. Researchers have explored its use in creating micelles and nanoparticles that can enhance drug bioavailability and target specificity.

The synthesis of Carbamic acid, bis(3-hydroxypropyl)-, 1,1-dimethylethyl ester involves multi-step organic reactions that require precise control over reaction conditions. The use of high-purity starting materials and catalysts is essential to ensure high yields and minimal byproduct formation. Advances in synthetic methodologies have enabled more efficient production processes, making this compound more accessible for research and development purposes.

The compound's role in biochemical research extends beyond enzyme inhibition. It has been used as a probe to study protein-ligand interactions at atomic resolution. X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy studies have provided insights into how Carbamic acid, bis(3-hydroxypropyl)-, 1,1-dimethylethyl ester interacts with target proteins. These structural insights have been invaluable in designing next-generation drugs with improved binding affinities and selectivity.

The future prospects of Carbamic acid, bis(3-hydroxypropyl)-, 1,1-dimethylethyl ester are promising as researchers continue to uncover new applications and refine synthetic methodologies. Its versatility as a building block for pharmaceutical intermediates positions it as a key component in the development of innovative therapeutics. As our understanding of biochemical pathways grows，so does the potential for this compound to contribute to advancements in medicine.

• 112275-50-0(Tert-butyl 1,4-diazepane-1-carboxylate)
• 152192-96-6((2-Hydroxy-ethyl)-propyl-carbamic acid tert-butyl ester)
• 86953-79-9(tert-Butyl pyrrolidine-1-carboxylate)
• 105628-64-6(tert-butyl N-(2-aminoethyl)-N-propylcarbamate)
• 68076-39-1(N1,N5-Bis-Boc-spermidine)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)